Anbio Biotechnology (NASDAQ:NNNN) Sees Unusually-High Trading Volume – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) saw unusually-strong trading volume on Wednesday . Approximately 152,184 shares changed hands during mid-day trading, an increase of 252% from the previous session’s volume of 43,212 shares.The stock last traded at $16.6050 and had previously closed at $15.70.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Anbio Biotechnology Trading Down 3.8%

The business’s 50 day simple moving average is $25.15.

Anbio Biotechnology (NASDAQ:NNNN) last released its earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.